Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
拉维达韦联合索非布韦治疗无肝硬化或代偿性肝硬化慢性丙型肝炎患者的疗效和安全性（STORM-C-1）：一项两阶段、开放标签、多中心、单臂 II/III 期试验的中期分析
期刊:Lancet Gastroenterology & Hepatology
影响因子:38.6
doi:10.1016/S2468-1253(21)00031-5
Andrieux-Meyer, Isabelle; Tan, Soek-Siam; Thanprasertsuk, Sombat; Salvadori, Nicolas; Menétrey, Caroline; Simon, François; Cressey, Tim R; Said, Hajjah Rosaida Hj Mohd; Hassan, Muhammad Radzi Abu; Omar, Haniza; Tee, Hoi-Poh; Chan, Wah Kheong; Kumar, Suresh; Thongsawat, Satawat; Thetket, Kanawee; Avihingsanon, Anchalee; Khemnark, Suparat; Yerly, Sabine; Ngo-Giang-Huong, Nicole; Siva, Sasikala; Swanson, Alistair; Goyal, Vishal; Bompart, Francois; Pécoul, Bernard; Murad, Shahnaz
